I doubt it. There was never any bona fide evidence that Sandoz was not taking a significant Lovenox share in the hospital setting, so Wheeler’s comment on today’s webcast, although bullish, is not exactly surprising.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”